Page last updated: 2024-08-24

isoimperatorin and Bone Loss, Osteoclastic

isoimperatorin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Deng, W; Li, H; Li, Y; Lin, Y; Liu, T; Mo, G; Qin, Q; Shao, Y; Tang, Y; Xu, L; Yuan, K; Zhang, S	1

Other Studies

1 other study(ies) available for isoimperatorin and Bone Loss, Osteoclastic

Article	Year
Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK. Biochemical pharmacology, 2023, Volume: 211 Topics: Animals; Bone Resorption; Cell Differentiation; Female; Furocoumarins; Humans; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; RANK Ligand; Rats; Reactive Oxygen Species; Receptor Activator of Nuclear Factor-kappa B; Transcription Factors	2023

Article

Year

Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK.

Biochemical pharmacology, 2023, Volume: 211

Topics: Animals; Bone Resorption; Cell Differentiation; Female; Furocoumarins; Humans; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; RANK Ligand; Rats; Reactive Oxygen Species; Receptor Activator of Nuclear Factor-kappa B; Transcription Factors

2023